Madeleine D Hu1, Natasha B Golovchenko1, Grace L Burns2, Prema M Nair2, Thomas J Kelly1, Jonathan Agos1, Mudar Zand Irani2, Wai Sinn Soh2, Matthew R Zeglinski3, Alexander Lemenze1, Edward M Bonder4, Inga Sandrock5, Immo Prinz6, David J Granville3, Simon Keely2, Alastair J M Watson7, Karen L Edelblum8. 1. Center for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey. 2. National Health and Medical Research Council Centre of Research Excellence in Digestive Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia, Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia. 3. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 4. Department of Biological Sciences, Rutgers University, The State University of New Jersey, Newark, New Jersey. 5. Institute of Immunology, Hannover Medical School, Hannover, Germany. 6. Institute of Systems Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 7. Department of Gastroenterology and Gut Biology, Norwich Medical School, University of East Anglia, Norwich, UK. 8. Center for Immunity and Inflammation, Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, New Jersey. Electronic address: ke163@njms.rutgers.edu.
Abstract
BACKGROUND & AIMS: Excessive shedding of apoptotic enterocytes into the intestinal lumen is observed in inflammatory bowel disease and is correlated with disease relapse. Based on their cytolytic capacity and surveillance behavior, we investigated whether intraepithelial lymphocytes expressing the γδ T cell receptor (γδ IELs) are actively involved in the shedding of enterocytes into the lumen. METHODS: Intravital microscopy was performed on GFP γδ T cell reporter mice treated with intraperitoneal lipopolysaccharide (10 mg/kg) for 90 minutes to induce tumor necrosis factor-mediated apoptosis. Cell shedding in various knockout or transgenic mice in the presence or absence of blocking antibody was quantified by immunostaining for ZO-1 funnels and cleaved caspase-3 (CC3). Granzyme A and granzyme B release from ex vivo-stimulated γδ IELs was quantified by enzyme-linked immunosorbent assay. Immunostaining for γδ T cell receptor and CC3 was performed on duodenal and ileal biopsies from controls and patients with Crohn's disease. RESULTS: Intravital microscopy of lipopolysaccharide-treated mice revealed that γδ IELs make extended contact with shedding enterocytes. These prolonged interactions require CD103 engagement by E-cadherin, and CD103 knockout or blockade significantly reduced lipopolysaccharide-induced shedding. Furthermore, we found that granzymes A and B, but not perforin, are required for cell shedding. These extracellular granzymes are released by γδ IELs both constitutively and after CD103/E-cadherin ligation. Moreover, we found that the frequency of γδ IEL localization to CC3-positive enterocytes is increased in Crohn's disease biopsies compared with healthy controls. CONCLUSIONS: Our results uncover a previously unrecognized role for γδ IELs in facilitating tumor necrosis factor-mediated shedding of apoptotic enterocytes via CD103-mediated extracellular granzyme release.
BACKGROUND & AIMS: Excessive shedding of apoptotic enterocytes into the intestinal lumen is observed in inflammatory bowel disease and is correlated with disease relapse. Based on their cytolytic capacity and surveillance behavior, we investigated whether intraepithelial lymphocytes expressing the γδ T cell receptor (γδ IELs) are actively involved in the shedding of enterocytes into the lumen. METHODS: Intravital microscopy was performed on GFP γδ T cell reporter mice treated with intraperitoneal lipopolysaccharide (10 mg/kg) for 90 minutes to induce tumor necrosis factor-mediated apoptosis. Cell shedding in various knockout or transgenic mice in the presence or absence of blocking antibody was quantified by immunostaining for ZO-1 funnels and cleaved caspase-3 (CC3). Granzyme A and granzyme B release from ex vivo-stimulated γδ IELs was quantified by enzyme-linked immunosorbent assay. Immunostaining for γδ T cell receptor and CC3 was performed on duodenal and ileal biopsies from controls and patients with Crohn's disease. RESULTS: Intravital microscopy of lipopolysaccharide-treated mice revealed that γδ IELs make extended contact with shedding enterocytes. These prolonged interactions require CD103 engagement by E-cadherin, and CD103 knockout or blockade significantly reduced lipopolysaccharide-induced shedding. Furthermore, we found that granzymes A and B, but not perforin, are required for cell shedding. These extracellular granzymes are released by γδ IELs both constitutively and after CD103/E-cadherin ligation. Moreover, we found that the frequency of γδ IEL localization to CC3-positive enterocytes is increased in Crohn's disease biopsies compared with healthy controls. CONCLUSIONS: Our results uncover a previously unrecognized role for γδ IELs in facilitating tumor necrosis factor-mediated shedding of apoptotic enterocytes via CD103-mediated extracellular granzyme release.
Authors: Madeleine D Hu; Alexander D Ethridge; Rebecca Lipstein; Sushil Kumar; Yitang Wang; Bana Jabri; Jerrold R Turner; Karen L Edelblum Journal: J Immunol Date: 2018-06-08 Impact factor: 5.422
Authors: F J Baert; G R D'Haens; M Peeters; M I Hiele; T F Schaible; D Shealy; K Geboes; P J Rutgeerts Journal: Gastroenterology Date: 1999-01 Impact factor: 22.682
Authors: Christopher T Turner; Matthew R Zeglinski; Katlyn C Richardson; Stephanie Santacruz; Sho Hiroyasu; Christine Wang; Hongyan Zhao; Yue Shen; Roma Sehmi; Hermenio Lima; Gail M Gauvreau; David J Granville Journal: J Invest Dermatol Date: 2020-06-03 Impact factor: 8.551
Authors: Annette C Wensink; Vera Kemp; Job Fermie; M Isabel García Laorden; Tom van der Poll; C Erik Hack; Niels Bovenschen Journal: Proc Natl Acad Sci U S A Date: 2014-04-07 Impact factor: 11.205
Authors: Monica D Prakash; Marcia A Munoz; Rohit Jain; Philip L Tong; Aulikki Koskinen; Matthias Regner; Oded Kleifeld; Bosco Ho; Matthew Olson; Stephen J Turner; Paulus Mrass; Wolfgang Weninger; Phillip I Bird Journal: Immunity Date: 2014-11-28 Impact factor: 31.745
Authors: Yaping Chen; Kevin Chou; Elaine Fuchs; Wendy L Havran; Richard Boismenu Journal: Proc Natl Acad Sci U S A Date: 2002-10-10 Impact factor: 11.205
Authors: Ken S Lau; Virna Cortez-Retamozo; Sarah R Philips; Mikael J Pittet; Douglas A Lauffenburger; Kevin M Haigis Journal: PLoS Biol Date: 2012-09-25 Impact factor: 8.029
Authors: R Kiesslich; C A Duckworth; D Moussata; A Gloeckner; L G Lim; M Goetz; D M Pritchard; P R Galle; M F Neurath; A J M Watson Journal: Gut Date: 2011-11-24 Impact factor: 23.059
Authors: Sho Hiroyasu; Matthew R Zeglinski; Hongyan Zhao; Megan A Pawluk; Christopher T Turner; Anika Kasprick; Chiharu Tateishi; Wataru Nishie; Angela Burleigh; Peter A Lennox; Nancy Van Laeken; Nick J Carr; Frank Petersen; Richard I Crawford; Hiroshi Shimizu; Daisuke Tsuruta; Ralf J Ludwig; David J Granville Journal: Nat Commun Date: 2021-01-12 Impact factor: 14.919
Authors: Eden Dubchak; Gideon Obasanmi; Matthew R Zeglinski; David J Granville; Sonia N Yeung; Joanne A Matsubara Journal: Front Pharmacol Date: 2022-09-20 Impact factor: 5.988